Rikta 04/4 additional emitter Shower 1(50)-04

Emitter SHOWER 1(50)-04

An additional emitter for the device RIKTA 04/4.

It is recommended for treatment of large areas of damage (burns, frostbite) as well as for  treatment of bone tissue diseases, problems with the spine. It is used in treatment of arthritis, arthrosis. Due to the larger area of ​​the emitter, all the necessary zones can be processed in one session, not exceeding the permissible doses, which reduces the duration of a treatment session.

The increased laser power (compared to the T1-04 emitter) up to 30 W per pulse, increases the impact efficiency and reduces recovery time.
It is completed with an additional separate methodological manual on the use of this particular emitter.
This emitter with a larger exposure area and increased power is optional and  intended for use with devices of the RIKTA 04/4 series.
The emitter is intended for therapeutic non-invasive treatment of large pathology zones. The main difference between Shower-1-04 emitter and the conventional base emitter is in the increased number of laser and infrared diodes (4 diodes of each type). The irradiation area of ​​the pathological field is increased (exposure zone) too compared to a conventional base emitter of 5 times and is 20 square centimeters (instead of 4 sq. cm with a standard emitter).
This makes it possible to  treat large pathological zones in patients quickly and efficiently: burns, phlebitis of superficial veins, trophic ulcers, skin diseases (psoriasis, lichen planus, alopecia areata, etc.).

Advantages of the emitter Shower-1-04

The advantage of the  emitter over the standard T1-04 is also that it is highly effective in various bone pathologies, in particular: bone fractures, calcaneal spur, coxarthrosis of the femoral head, arthritis and arthrosis, ankylosing spondylitis.
The Shower emitter is widely used in cosmetology practice, for treating facial skin in order to improve skin blood flow, and, accordingly, improve skin trophism (nutrition). Another advantage of the emitter -  no need for laser hemotherapy.
However, it should be remembered that when exposed to laser radiation on areas with large vessels, the power of laser and infrared radiation should be reduced to 25%. When treating liver and kidney pathologies, the power of laser and infrared radiation should also be reduced to 25%, while there should be a gap of 1.5-2 cm between the skin and the emitter.

Impact factors

• Pulsed infrared laser radiation (up to 30 W, 905 nm);
• Pulsating broadband infrared radiation (60 mW, 875 nm);
• Pulsating radiation in the red (visible) part of the spectrum (7 mW, 640 nm);
• Permanent magnetic field (35 mT).